FDA approves new injectable drug to treat schizophrenia
Tuesday, October 6, 2015 - 08:20
in Health & Medicine
On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks. Schizophrenia is a chronic, severe and disabling brain disorder affecting about one percent […]